Table 1 HPV genotype distribution in the different EDiTH studies
From: Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
Invasive cervical cancers | High-grade cervical neoplasias | Low-grade squamous intraepithelial lesions | External acuminata condylomata | Anal cancer | Oropharyngeal carcinomas | |
|---|---|---|---|---|---|---|
n | n | n | n | n | n | |
HPV (+) | 501 (97.1) | 484 (98.2) | 390 (98.2) | 418 (98.8) | 354 (96.7) | 146 (46.5) |
HPV (-) | 15 (2.9) | 9 (1.8) | 7 (1.8) | 5 (1.2) | 12 (3.3) | 168 (53.5) |
Total | 516 (100) | 493 (100) | 397 (100) | 423 (100) | 366 (100) | 314 (100) |
Total single infections | 386 (74.8) | 333 (67.5) | 192 (48.4) | 281 (66.4) | 265 (72.4) | 138 (43.9) |
Total single infections 6/11/16/18 | 316 (61.2) | 203 (41.2) | 50 (12.6) | 248 (58.6) | 234 (63.9) | 130 (41.4) |
Single infections 6 | 1 (0.2) | 0 (0.0) | 11 (2.8) | 195 (46.1) | 13 (3.6) | 0 (0.0) |
Single infections 11 | 1 (0.2) | 1 (0.2) | 0 (0.0) | 42 (9.9) | 4 (1.1) | 0 (0.0) |
Single infections 16 | 275 (53.3) | 199 (40.4) | 31 (7.8) | 11 (2.6) | 216 (59.0) | 130 (41.4) |
Single infections 18 | 39 (7.6) | 3 (0.6) | 8 (2.0) | 0 (0.0) | 1 (0.3) | 0 (0.0) |
Total single infections 31/33/45/52/58 | 46 (8.9) | 96 (19.5) | 34 (8.6) | 3 (0.7) | 23 (6.3) | 0 (0.0) |
Single infections 31 | 17 (3.3) | 41 (8.3) | 8 (2.0) | 1 (0.2) | 4 (1.1) | 0 (0.0) |
Single infections 33 | 11 (2.1) | 27 (5.5) | 1 (0.3) | 0 (0.0) | 11 (3.0) | 0 (0.0) |
Single infections 45 | 9 (1.7) | 0 (0.0) | 6 (1.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Single infections 52 | 6 (1.2) | 13 (2.6) | 8 (2.0) | 1 (0.2) | 5 (1.4) | 0 (0.0) |
Single infections 58 | 3 (0.6) | 15 (3.0) | 11 (2.8) | 1 (0.2) | 3 (0.8) | 0 (0.0) |
Total single infections 6/11/16/18/31/33/45/52/58 | 362 (70.2) | 299 (60.6) | 84 (21.2) | 251 (59.3) | 257 (70.2) | 130 (41.4) |
Single infections others | 24 (4.7) | 34 (6.9) | 108 (27.2) | 30 (7.1) | 8 (2.2) | 8 (2.5) |
Total multiple infections | 115 (22.3) | 151 (30.6) | 198 (49.9) | 137 (32.4) | 89 (24.3) | 8 (2.5) |
Multiple infections 6/11/16/18 excluding any other HPV genotypes | 41 (7.9) | 11 (2.2) | 4 (1.0) | 19 (4.5) | 24 (6.6) | 0 (0.0) |
Multiple infections 6/11/16/18 with or without another HPV genotype | 108 (20.9) | 116 (23.5) | 83 (20.9) | 125 (29.6) | 76 (20.8) | 3 (1.0) |
Multiple infections 6/11/16/18/31/33/45/52/58 excluding any other HPV genotypes | 74 (14.3) | 79 (16.0) | 19 (4.8) | 39 (9.2) | 39 (10.7) | 0 (0.0) |
Multiple infections 6/11/16/18/31/33/45/52/58 with or without another HPV genotype | 113 (21.9) | 142 (28.8) | 139 (35.0) | 131 (31.0) | 84 (23.0) | 8 (2.5) |
Multiple infections other HPV excluding 6/11/16/18/31/33/45/52/58 | 2 (0.4) | 9 (1.8) | 59 (14.9) | 6 (1.4) | 5 (1.4) | 0 (0.0) |